Research Reports

Confectionery Market, Size, Share, Outlook and Growth Opportunities 2019-2026

5:54 pm 27 July 2020

Market Overview

Confectionery is the group of food products that are made with sugar or carbohydrates. There is wide collection of confectionery products across the globe and are majorly classified as chocolate confectionery, sugar confectionery, and bakers’ confectionery. Most of the well-known products such as candies, gums, lollipops, and chocolates are included in confectionery.
The Global Confectionery Market is expected to grow at a CAGR of 4.20% during the forecasting period (2019-2026).

Download free sample: https://www.datamintelligence.com/download-sample/confectionery-market

Market Dynamics:

The health benefits associated with chocolate products are driving the growth of the overall confectionery market, specifically dark chocolate. Dark chocolate is considered as a healthy snack owing to its nutrient content and its potential in lowering the risk of heart disease. Epidemiologists across the globe are suggesting consumption of dark and milk chocolate for heart health with clinically proven and study based facts. In a recent study of Harvard Medical School on 21,000 residents of England, it is found that consumption of up to 3.5 ounces of chocolate a day lowered the risk of heart disease in adults. Furthermore, innovations in the market in terms of flavor and nutritional content is driving the market growth. Global confectionery manufacturers are focusing on the development of confectionery products with flavors such as coffee, fruits, cinnamon, and different ingredients. For instance, in February 2019, Nestlé S.A. launched a premium chocolate derived from raspberries and ruby cocoa beans in the American market and this confectionery product is estimated to gain significant sales in the valentine season. Companies such as Mars Wrigley Confectionery are likely to mark product innovations catering the burgeoning interest towards nut-butters and mixed fruit flavors.
The rising consciousness among consumers towards sugar intake is the primary factor hindering the growth of the confectionery market. Sugar present in confectionery products is considered as a leading cause for diseases such as Obesity and Diabetes. The rising prevalence of obesity and diabetes is limiting the consumer base for confectionery across the globe. The global Diabetes community in the U.K. suggests to avoid chocolate consumption in people with blood sugar levels higher than recommended levels. However, this is resulting in immense growth potential for sugar-free confectionery products. A product labeled sugar-free use sugar substitutes such as saccharin and aspartame or sugar alcohols for sweetening, all without adding calories to the product, thus making them the confectionery of choice for Diabetic and health-savvy population. The evolution of sugar-free, low-calorie products is a potential opportunity for the confectionery market across the globe.

Market Segmentation

The global confectionery market has been segmented by product type into sugar confectionery, chocolate confectionery, and bakers’ confectionery. The large market for hard candies across the globe made sugar confectionery as the largest segment of the global confectionery market. Sugar confectionery is widely accepted and preferred by the population of almost all groups and this segment is likely to hold its dominance on the market over the forecast period. The United States Department of Agriculture in its recent press release stated that millennials and generation X accounted for nearly 50% of the candy sales in the U.S. in 2017. However, the growing demand for chocolate products owing to its low-sugar content and health benefits resulted in chocolate confectionery as the fastest-growing segment. Chocolate confectionery is likely to grow at a lucrative CAGR of over 6.2% during the forecast period. Supermarkets and hypermarkets evolved as the largest sales channel for confectionery products with a share of nearly 40% in terms of sales value in 2018. Bakeries and restaurants, convenience stores, and e-commerce are also holding a significant share in the sales of convenience products.
By geography, the study is segmented into North America, South America, Europe, Asia Pacific, Middle East, and Africa.
Confectionery is a well-established market since decades in most of the American and European countries. The availability of cocoa and other confectionery ingredients made them the early adopters of sugar and chocolate confectionery products. Europe is the largest confectionery market with a share of over 35% in 2018 and it is estimated to hold its dominance over the forecast period. The large per-capita consumption of chocolate in countries such as Switzerland, the U.K., Sweden, Germany, and Ireland is supporting the growth of confectionery market in Europe. However, Asia Pacific evolved as the fastest growing market for confectionery products owing to the rising consumer spending and growing adoption of confectionery in countries such as India and China. According to India Brand Equity Foundation (IBEF), chocolate sales in India increased from less than $100 million in 2000 to over $1,500 million in 2017.
The global confectionery market is highly fragmented with large number of players involved in wide array of confectionery products. However, companies such as Nestlé S.A., Cadbury, Mondelez, and The Hershey Company evolved as market leaders with consumer loyalty and brand reputation. The market turned further competitive by the foot prints of many Asian and Middle East companies entering the market with local confectionery flavors. The companies in the market are leveraging on acquisitions, mergers and new product formulations to increase their market share. For instance, in April 2018, Ferrero SpA, an Italian chocolate and confectionery products manufacturer had acquired the confectionery business of Nestle in U.S., thus boosting its portfolio of confectionery products in North America market. Furthermore, the company also The Ferrara Candy Company, another U.S. based confectionery manufacturer in 2017 for approximately $1.3 billion. These activities witness the interest of the company to boost its presence in the non-chocolate confectionery segment.
Other key players in the market are Delfi Limited, Mars, Incorporated, Lotte Confectionery, Parle Products Pvt. Ltd., and Grupo Arcor.

Key Takeaways from the Report

The chocolate confectionery products market in Western Europe region is well-established with high per-capita consumption. According to DataM analysis, Western Europe is the largest market for chocolate confectionery products, followed by North America and Asia Pacific region
Changing eating preferences and rising trend of gifting confectionery products led to the rise in confectionery market in Asia Pacific region

View full report: https://www.datamintelligence.com/research-report/confectionery-market

Enquiry before buying: https://www.datamintelligence.com/enquiry/confectionery-market

About Us

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Cloud Seeding Equipment Market, Size, Share, Outlook and Growth Opportunities 2019-2026

5:53 pm 27 July 2020

Market Overview

The Global Cloud Seeding Equipment Market is expected to grow at a CAGR of 5.5% during the forecasting period (2019-2026).
Cloud seeding is a process to alter the weather conditions that comprises injecting clouds with chemical agents in order to modify the climate to our will. This is mainly done by diffusing substances that affect the microphysical processes within the cloud. These ‘substances’ are either serve as cloud condensation nuclei or ice nuclei that are generally used for increasing the precipitation, or fog and hail suppression.

Download free sample: https://www.datamintelligence.com/download-sample/cloud-seeding-equipment-market

Market Dynamics

The global cloud seeding equipment market is primarily driven by increasing concerns for water scarcity in arid regions across the world, due to the threat of climate change and global warming. Government initiatives promoting cloud seeding in areas facing dry spells is also a major factor which boosts the Global Cloud Seeding equipment Market. The United Nations predicts that 14% of the world’s population will suffer from water scarcity by 2025.
High costs of implementation and lack of effectiveness on this process are factors which restrain the market.

Market Segmentation

By Type, the Global Cloud Seeding Market is segmented into Aerial Cloud Seeding Equipment and Ground-Based Cloud Seeding Equipment. Aerial Cloud Seeding Equipment has dominated the market due to its effectiveness and the ease of covering large areas in a short span of time. Another reason why users prefer Aerial Cloud Seeding Equipment is due to its cost-effectiveness of this process as compared to Ground-Based Cloud Seeding, per 1000 litres produced.
However, the Ground-Based Cloud Seeding Equipment is also expected to grow in the forecast period primarily from the developing countries. For instance, Chinese The government aims to use Ground-Based Cloud Seeding Equipment in the hopes of regulating the natural water supply in China.
By Applications, the Global Cloud Seeding Equipment Market is segmented into seeding for Fog Dissipation, Snowfall and Rainfall Augmentation, Hail Suppression, and others. Owing to the rarity of occurrences in events such as hailstorms, the need for cloud seeding equipment to prevent such events is also minimal. Therefore, the dominant segment in this market is the Snowfall and Rainfall Augmentation. Various countries have used this technique for number of times in areas where they facing severe droughts.
Fog dissipation, on the other hand, is also expected to grow during the forecast period due to growing businesses in various cities, especially in developing countries, which mean an increase in the infrastructural conditions and therefore increased number of airports. As cloud seeding equipment for fog dissipation is used mainly by airports for easy transit of planes.

Geographical Analysis

By Geography the market is segmented as North America, South America, Europe, Asia Pacific, and Middle East and Africa. The Global Cloud Seeding Market is projected to be concentrated in the APAC region, with China leading the world in terms of market share. China has been spending extensively on cloud seeding to achieve maximum independence from unpredictable rains, and make their own water supply. The Chinese officials estimate that 10 billion cubic metres (1 cubic metre = 1000 Litres) of additional rainwater will be produced through cloud seeding. This is a part of its efforts to make their own ‘Tianhe’ or Sky River which is expected to cover 1.6 million sq. kilometres. Cloud seeding programs are underway in India, as well, with the states of Andhra Pradesh, Tamil Nadu and Maharashtra seriously considering this option due to extreme water shortage and drought.
The European Region is also expected to have a healthy growth rate in this market, as there are increased efforts to reduce the dependence of countries’ water supply on erratic rains, and build their own ‘rain cycle’. Russia is the nation leading this market in Europe, with the government spending up to a million dollars on every occasion just to ensure it doesn’t rain during the celebrations.

Competitive Analysis

The Global Cloud Seeding Equipment Market is moderately fragmented market, with no market player holds a major market share. However, the market players themselves are limited in number. The market players in this segment have an immense need to collaborate with government officials. Optimizing the process to cut costs will eventually lead to a greater demand for cloud seeding equipment market.
North American Weather Consultants, a major player in cloud seeding equipment market has come up with an initiative to improve market presence through Technology Transfer to its clients.

Key Takeaways

The Global Cloud Seeding Equipment Market is still in initial stages of development and offers great opportunities for growth, with the rising problems on water shortages and global warming.
Market Players have an opportunity to capitalize on the anticipated boom in demand by cutting costs in the process of cloud seeding, or by initiating new policies which boost product acceptance.
Although the market as a whole is not highly fragmented, new entrants with a significant level of knowledge of bureaucratic processes will be able to have profitable businesses.

View full report: https://www.datamintelligence.com/research-report/cloud-seeding-equipment-market

Enquiry before buying: https://www.datamintelligence.com/enquiry/cloud-seeding-equipment-market

About Us

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Cognitive Computing Market, Size, Share, Outlook and Growth Opportunities 2019-2026

5:53 pm 27 July 2020

Market Overview

The Global Cognitive Computing Market is expected to grow at a CAGR of 21% during the forecasting period (2019-2026). Cognitive computing helps to process volumes of complex data, thereby inadvertently enhancing the enterprise's productivity levels. Cognitive computing is considered as a next-generation system that converses in human language and helps experts to make better decisions by understanding the complexities of big data. In the current scenario, most of the data received is unstructured such as images, videos, natural language, and symbols. Increasing volume of unstructured data and advancements in technology are the major driving forces of the market.
Cognitive computing systems are typical combination of hardware and software that constitute natural language processing (NLP) and machine language, and have capability to collect, process, and interpret the dark data available with business organizations. Cognitive computing systems works exactly the phenomena of how a human brain works. These systems can process natural language, unstructured data, and can learn from experiences in similar way a human being do.
The report covers all the major trends and drivers playing a vital role in the growth of the global Cognitive Computing Market. The market has been segmented based on region, deployment, application, and technology.

Download free sample: https://www.datamintelligence.com/download-sample/cognitive-computing-market

Market Dynamics

The global Cognitive Computing Market growth is primarily driven by the presence of enormous data with business organizations in the form of human language, videos and pictures which contain valuable information. Hence, to process this data, there is a strong need for cognitive analytic technologies such as NLP and machine learning. This immensely help business organizations to control the risk associated with their business. Therefore, growing need to process unstructured and complex dark data set is expected to further boost global cognitive computing market over the forecast period.
In addition, rise in penetration of cloud-based solutions, growth associated with artificial intelligence and machine learning, and increase in market for prediction solutions also fuel the demand for cognitive computing.
However, dearth of trained professionals is expected to restrain the cognitive computing market growth during the forecast period.

Market Segmentation

By deployment, the global Cognitive Computing Market is segmented into cloud -based solutions and on-premise solutions. In 2018, cloud deployment segment accounted for the largest market share in the global market. Cloud technology enables developers to adopt Agile workflows, significantly reducing lead times in testing and deploying new products and releasing product updates. Cloud-based technological advancements, development of innovative hardware and software systems and cognitive experience interfaces would foster the growth of the cognitive computing market.
By vertical, the global Cognitive Computing Market is segmented into BFSI, Healthcare & Life sciences, Telecommunications and ITES, Government and Public sector, and Others. In 2018, BFSI vertical accounted for the majority share in the market. The BFSI is the most targeted industry vertical, as it deals with large volumes of sensitive and private financial data. The impact of this factor is expected to be higher in future, since machine-learning algorithms are anticipated to be used for preventing payment frauds and cyberterrorism. Furthermore, cognitive computing is anticipated to have a strong impact on healthcare advancements and lead to more accurate treatments and prevention of medical conditions.

Regional Analysis

By geography, the global Cognitive Computing Market is segmented into North America, Asia-Pacific (APAC), Europe, South America, and the Middle East and Africa (MEA).
In 2018, North America accounted for the largest market share. However, APAC is expected to witness a higher CAGR than other regions during the forecast period. North America is a matured market in terms of cognitive computing adoption, due to various factors, such as standards, regulations, advanced IT infrastructure, the presence of a large number of enterprises, and the availability of proficient technical expertise. Therefore, North America is expected to grow at a steady and maintain its dominant position in the global market over the forecast period.
APAC Cognitive Computing Market is expected to grow exponentially over the forecast period due to an increased demand for cloud computing among small and medium-sized enterprises (SMEs). Countries like Singapore, which has seen ICT infrastructure as a key enabler in boosting the overall competitiveness in the region, based on creating new industries and new businesses, thereby encouraging economic growth. The city-state boasts a prime position among its neighbors’ when it comes to cloud computing adoption. In India, at present, it does not have a mature ecosystem that supports cloud IaaS services.

Competitive Analysis

Global Cognitive Computing Market is moderately concentrated with the presence of global and few regional players in the market. Major players with prominent shares in the market are focusing on expanding their customer base across foreign countries. These companies are leveraging on strategic collaborative initiatives to increase their market shares and profitability.
Some major players in the market are IBM, Microsoft, Google, Palantir, Saffron Technology, Cognitive Scale, Numenta, Vicarious, Enterra Solutions, Cold Light, and among others. These players have adopted various strategies, such as new product/service developments, mergers and acquisitions, collaborations, and partnerships, to expand their presence in the global Cognitive Computing Market.
In June 2019, CognitiveScale Inc., an Enterprise AI software pioneer, has expanded its strategic relationship with Microsoft to further accelerate adoption of CognitiveScale’s Cortex software amongst businesses using Microsoft Azure.

View full report: https://www.datamintelligence.com/research-report/cognitive-computing-market

Enquiry before buying: https://www.datamintelligence.com/enquiry/cognitive-computing-market

About Us

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

C-Arms Market, Size, Share, Outlook and Growth Opportunities 2019-2026

5:52 pm 27 July 2020

Market Overview

The Global C-Arms Market is forecasted to grow at a CAGR of 3.5 % during the forecast period (2019-2026).
C-arm is a medical device that is used in imaging for several applications such as orthopedic, surgical, critical care, and emergency care procedures. The C-shaped arm are used to connect x-ray source and x-ray detector that precisely and accurately reduces patient discomforting in various types of surgical and non-surgical procedures.

Download free sample: https://www.datamintelligence.com/download-sample/c-arms-market

Market Dynamics

The C-Arms market growth is driven by several factors such as rising incidence of chronic diseases, technological advancements in imaging devices, growing geriatric population and increasing demand for imaging in emerging economies.
Imaging systems is a vital technology and are present in nearly all well-equipped hospitals. Specialists in applications, such as surgery, orthopedics, traumatology, vascular surgery, and cardiology use C-arms for intraoperative imaging. The devices provide high-resolution X-ray images in real-time, which help physicians to monitor progress at any point during the operation and immediately make necessary corrections. As a result, treatment results are better, and the patient’s recovery is faster. Hence, the demand for c-arms is increasing in different applications.
According to the World Health Organization (WHO), 2018 data, the burden of chronic diseases is rapidly increasing globally. In 2001, chronic diseases contributed approx. 60% of the 56.5 million total reported deaths in the world and approximately 46% of the global burden of disease. It has been projected that, by 2020, chronic diseases will account for almost three-quarters of all deaths worldwide, and that 71% of deaths due to ischemic heart disease (IHD), 75% of deaths due to stroke, and 70% of deaths due to diabetes will occur in developing countries. The number of people in the developing world with diabetes will increase by more than 2.5-fold, from 84 million in 1995 to 228 million in 2025. Thus, with rising cases of chronic diseases, the demand for imaging systems such as c-arms is increasing for diagnosis of the diseases.
One of the leading advancements in C-arm development has been the transition to digital detectors for improved image quality. The market players are also taking into consideration the demanding environments in which the systems are used and making them easier for operators to maneuver. For instance, Siemens entered the digital detector market in 2014 with the release of the Cios Alpha. The system features a 25 kW output and a field of view the company claims is 25 percent larger than conventional C-arms. Also, In May 2019, ControlRad, Inc., a privately held medical technology company focused on dramatically reducing unnecessary radiation exposure during fluoroscopically guided procedures, launched the U.S. Food and Drug Administration (FDA) approved, ControlRad Trace. The ControlRad Trace is the only technology that can be integrated into existing mobile C-arms to reduce radiation in any fluoroscopic imaging procedure.
With rising adoption of portable C-arms, there is a significant market opportunity for major players manufacturing mini C-arms. Several mini c-arms are designed explicitly for extremity imaging and have a smaller footprint, along with increased mobility compared to the full-size c-arms. Currently available systems in the mini c-arm category vary significantly in size and cost depending upon the functionality offered for the procedures. Manufacturers are differentiating their products based on mobility, the field of view, and by including alternate imaging technologies. For instance, OrthoScan Inc.’s FD Pulse is the world’s first mini C-Arm equipped with pulsed fluoroscopy

Market Segmentation

By type, the global C-Arms market is segmented into fixed-C arms and mobile C-arms. Among these, mobile c-arms are growing at the highest CAGR during the forecast period (2019-2026), owing to the rising number of interventional procedures, flexibility of mobile C-arms and cost-effective for image guidance during procedures across the hospital. The mobile C-arms offers greater interdepartmental flexibility for interventional procedures; thus, most hospitals employ mobile systems. The mobile C-arms are often found in surgical suites, while fixed systems live in the radiology department or the cardiac catheterization lab. Mobile C-arms are further classified as full-Size C-Arms and mini C-Arms.
Based on applications of c-arms, the market is segmented into cardiology, radiology/oncology, neurology, gastroenterology, trauma, and others. Among these, cardiology is estimated to grow at a significant CAGR during the forecast period. According to CDC, cardiovascular disease (CVD) remains the leading cause of death globally. For instance, in the United States, there were about 840,768 deaths (635,260 cardiac) in 2016 from CVD. Coronary heart disease is the most common type of heart disease, killing about 366,000 people in 2015. With rising demand for inging in cardiovasucular disease, the manufacturers are introducing new systems equipped with c-arms to meet the hospitals need. C-arm computed tomography is used in cardiac imaging and offers the potential for three-dimensional imaging of the cardiac anatomy within the interventional environment. Hospitals are now able to address their interventional cardiology needs with Toshiba America Medical Systems, Inc.’s newest X-ray system, the Infinix Essential. The Infinix Essential is an ideal value system with its slim, off-center C-arm design, which allows steep angulations for optimized vessel profiling during cardiac interventions.
By end-users, the market is segmented into hospitals, diagnostic centers, and others. With rising prevalence of interventional procedures, the demand for medical imaging is on rise, hence mobile C-arms and the versatility they offer is becoming an important tool for hospitals. Hospitals are also benefited by cost savings through fewer follow-up operations and from minimized installation efforts.

Geographical Analysis

North America is dominating the C-Arms market in 2018 and estimated to hold largest market size over the forecast period (2019-2026), owing to the rising prevalence of chronic diseases, rising healthcare standards, and advancement in technology for imaging. According to the U.S. National Center for Health Statistics, chronic diseases affect approx. 133 million Americans, representing more than 40% of the total population of the country. By 2020, it is projected to grow to an estimated 157 million, with 81 million having multiple conditions. Hence, the demand for imaging devices such as C-arms is increasing with rising cases of chronic diseases. The U.S. has the highest installed base of C-arms in worldwide due to the rising standards of healthcare infrastructure in the United States. In addition, due to the stringent regulations in the United States, according to the healthcare regulatory authorities, all the C-arms are replaced as per the replacement schedule, which ensures that the new sales of C-Arms in the United States are consistent.

Competitive Landscape

The C-Arms market is dominated by few major players including GE Healthcare, Canon Medical Systems Corp., Hologic Corp., Siemens Healthineers AG, Koninklijke Philips NV, OrthoScan Inc., Shimadzu Corp., Ziehm Imaging GmbH, Toshiba Corporation, and Varian Medical Systems. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations which are contributing to the growth of the C-Arms market globally. For instance,
In February 2019, Philips, a global leader in health technology, launched Philips Zenition, a new mobile C-arm imaging platform. The Zenition mobile C-arm platform brings together innovations in image capture, image processing, ease-of-use and versatility pioneered on Philips’ Azurion platform.
In August 2018, Kiran Medical Systems, the Radiology Division of Trivitron Healthcare launched complete portfolio of Advanced Digital X-Ray systems, DSA C-Arm, Modular Smart OT Solutions and Satin Touch Radiation Protection Products.
In November 2018, Siemens Healthineers received the U.S. Food and Drug Administration (FDA) clearance of the Cios Spin, a new mobile C-arm that delivers precise 3-D images for intraoperative quality assurance.
In January 2018, Hologic Inc. launched the next generation in mini C-arm imaging, the Fluoroscan InSight FD Mini C-Arm, the latest product illustrating the company’s commitment to addressing the continuum of skeletal health care.

View full report: https://www.datamintelligence.com/research-report/c-arms-market

Enquiry before buying: https://www.datamintelligence.com/enquiry/c-arms-market

About Us

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Bubble Tea Market, Size, Share, Outlook and Growth Opportunities 2019-2026

5:51 pm 27 July 2020

Market Overview

The Global Bubble Tea Market is expected to grow at a CAGR of 8.1% during the forecasting period (2019-2026).
Bubble tea is a Taiwanese recipe made by blending a tea base with milk, fruit and fruit juices, then adding the signature “bubbles” - tapioca pearls that sit at the bottom. These fruit or tea infusions can be served either piping hot or iced cold, making a ever-so-quirky drink and snack. Bubble tea is usually served in transparent cups with a fat straw so that - as you sip - the tapioca balls (also known as “pearls” or “boba”) come shooting up it and can be chewed as you swallow down the liquid. It’s called bubble tea both because of the tapioca balls, and the floating “bubbles” created by the vigorous shaking involved in its blending.

Download free sample: https://www.datamintelligence.com/download-sample/bubble-tea-market

Market Dynamics

The global Bubble Tea Market is primarily driven by health benefits that are associated with the bubble tea. The bubble tea with the base ingredients as green tea and black tea have various health benefits associated as reduced risk of cardiovascular disease, diabetes, arthritis and even cancer. This is due to the presence of polyphenols which have anti-inflammatory and antioxidant properties. Moreover, tea production rise in countries like China, India and others because of the increase in demand by the people as base ingredient in bubble tea.
With the increasing flavors options and innovative launches in the bubble tea is also driving the market for the forecast period. A few of the most common flavors preferred by users in bubble tea comprises of chocolate, passion fruit, honeydew, taro, plum, lychee, strawberry, ginger, coffee, peach, and mango.
For instance, in Japan, sushi shop chain Sushiro has collaborated with popular Taiwanese bubble tea chain Sharetea to create a boba milk tea that comes with glowing pearls, served up on Sushiro’s conveyor belts. This new beverage is called “Hikaru golden bubble tea”, and was launched on July 19, 2019.
However, due to use of Addition artificial preservatives & color and excess sugar in the bubble tea which is making it unhealthy. Hence, hampering the growth of Bubble Tea.

Market Segment Analysis

By Base Ingredient type, the global Bubble Tea Market is segmented into Black Tea, Green Tea and others. Black Tea has the dominant position in the Bubble Tea and is expected to retain its dominance in the forecasted period. However, due to high health benefits and less calories the market for green tea is going to increase with rapid rate in the forecast period. It is expected that Black Tea product will grow at a CAGR of ~XX% during the forecast period.

Geographical Analysis

By geography, the global Bubble Tea Market is segmented into North America, Asia-Pacific (APAC), Europe, South America, and Middle East and Africa (MEA).
Asia-Pacific (APAC) holds the largest market share for Bubble Tea. Due to the population growth and the affordable drink with high health benefits is driving the market in the region. However, Europe is after APAC in terms of market share of Bubble Tea, increasing demand for healthy drinks because of awareness among people for the healthy food and drink.

Competitive Analysis

Key players are adopting strategies such as investing in R&D, new product launches, expansion in distribution channels to stand out as strong competitors in the market. Global Bubble Tea is a competitive market with the presence of various global and regional players in the market. The major players include Bubble Tea House Company, Bobabox Limited, Cuppotee, and Fokus Inc. Other key players in the market include Gong Cha, Lollicup USA Inc., Sumo's (M) Sdn Bhd, Ten Ren's Tea Time, Troika JC.
In February 2019, Boba Box Limited introduces 14 new flavours in European market. And are confident enough to attract wide audience for the bubble tea market.
In July 2019, Secret Recipe Brand introduces New Boba Series. There will be a total of (8) different flavours in the Boba series which are: Boba Milk Tea, Boba Caramel Milk Tea, Boba Brown Sugar Milk Tea, Boba Brown Sugar with Milk, Boba Cham, Boba Kopi-C, Boba Midnight Blue and also Boba Signature Fruit Tea.

View full report: https://www.datamintelligence.com/research-report/bubble-tea-market

Enquiry before buying: https://www.datamintelligence.com/enquiry/bubble-tea-market

About Us

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Biomarkers Market, Size, Share, Outlook and Growth Opportunities 2019-2026

5:50 pm 27 July 2020

Market Overview

The Global Biomarkers Market is expected to grow at a CAGR of 12.5% during the forecasting period (2019-2026). Biomarkers are used for the diagnosis health status of an individual. In medical terms, a measurable biomarker is a chemical component which reflects the presence as well as the severity of the disease. Biomarkers have an important function in the early detection of various diseases.

Download free sample: https://www.datamintelligence.com/download-sample/biomarkers-market

Market Dynamics

The Biomarkers market growth is driven by therising ageing population and increasing incidence of chronic diseases such as cancer, cardiovascular diseases and neurological disorders. In addition, increasing regulatory approval for biomarkers, rising demand in drug discovery, growing emphasis on personalized medicine and companion diagnostics are some of the other factors driving the growth of the biomarkers market globally. For instance, according to Globocan, the incidence rate of cancer types is increasing notably for many cancer types globally. The incidence of all cancer types worldwide is anticipated to increase at a CAGR of 2.5% during 2015-2030. Also, approval and product launches of biological and targeted therapies have positively impacted the global biomarker in the past few years and the trend is anticipated to be the same in the forecast period as well. For instance, In May 2018, the FDA approved Loxo application for biomarker-driven cancer drug. In November 2018, the U.S. Food and Drug Administration (FDA) approved the molecularly targeted therapeutic larotrectinib (Vitrakvi) for use based on whether a patient’s tumor tests positive for a specific genetic biomarker and not where in the body the tumor originated. Hence, with rising product launches and approvals, the market is growing rapidly globally.
However, high investment costs and problems associated such as sample storage & collection is hampering the growth of the biomarker market. Also, unfavorable reimbursement scenarios are expected to hinder the market growth during the forecast period.

Market Segment Analysis

On the basis of product type, the global biomarkers market is segmented into safety biomarkers, efficacy biomarkers, and validation biomarkers. Among these, Efficacy biomarker segment accounted for the largest market share and growing at a significant CAGR. Wide usage in oncology and antiretroviral treatment coupled with numerous research on identification of efficacy biomarkers should drive segment growth in projected timeframe.
Among disease indication, cancer segment occupied a significant market share in 2018 due to rising cancer prevalence globally. According to WHO, cancer is the second leading cause of death globally, and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer. Approximately 70% of deaths from cancer occur in low- and middle-income countries. Biomarkers help in differential diagnosis, risk assessment and monitoring of disease progression in oncology field. Availability of several cancer biomarkers for detection of different kinds of cancer including ovarian cancer, breast cancer and leukemia will foster segment growth in recent years.
The pharmaceutical companies are forming agreements with molecular diagnostic companies to for accelerating results biomarker testing. For instance, in Dec 2017, Biocartis Group NV signed a companion diagnostic development agreement with Amgen for the Idylla RAS biomarker tests. The agreement aims to register the Idylla RAS biomarker tests with the FDA as a companion diagnostic test for Amgen's drug Vectibix. In August 2018, FDA approved Roche’s Cobas EGFR Mutation Test V2 as a companion diagnostic test with AstraZeneca's cancer drug Iressa (gefitinib) for first-line treatment of patients with NSCLC. In July 2018, Nucleix, an Israeli molecular diagnostics firm, received $2.9 million Horizon 2020 grant from the European Commission to continue development of its lung cancer screening test, Lung EpiCheck. With the new funding, Nucleix anticipates to push Lung EpiCheck into US and European clinical trials in early 2019.

Market Geographical Analysis

North America is dominating the global Biomarkers market in 2018 and estimated to hold largest market size over the forecast period (2019-2026). The U.S. biomarkers market will lead biomarkers market due to favorable healthcare infrastructure as well as availability of technologically advanced products. Rising investment in drug discovery, diagnostics along with rising cancer patient pool will further stimulate the biomarkers market growth. According to the National Cancer Institute, in 2018, an estimated 1,735,350 new cases of cancer are diagnosed in the United States and 609,640 people die from the disease. The most common cancers are breast cancer, lung and bronchus cancer, prostate cancer, endometrial cancer, leukemia, pancreatic cancer, thyroid cancer, and liver cancer. The number of new cases of cancer (cancer incidence) is 439.2 per 100,000 men and women per year (based on 2011–2015 cases). Increased funds and support from government bodies for biomarker discovery, and growing number of FDA approvals for biomarkers is expected to positively influence the market in the future. For instance, in Jun 2018, Halozyme Therapeutics, a biotechnology company developing novel oncology and drug-delivery therapies, presented data evaluating certain biomarkers as potential predictors of survival in patients with previously untreated metastatic pancreatic ductal adenocarcinoma at the American Society of Clinical Oncology (ASCO).

Competitive Analysis

The Biomarkers market is a highly consolidated market, with major shared obtained by most of the emerging and local players. Some of the major players include Bio-Rad Laboratories Inc., Merck Millipore, Qiagen N.V., Siemens Healthcare, Abbott Laboratories, Affymetrix Inc., (Thermo Fisher Scientific), Signosis, Inc., EKF Diagnostics Holdings, Inc., Biosims Technologies Sas, and Cisbio Bioassays.
The key players are adopting various key strategies such as product launches, mergers & acquisitions, and collaborations which are contributing to the growth of the biomarkers market globally. For instance,
In April 2019, Synapse launched a new Innovative Medicines Initiative project, the Translational Safety Biomarker Pipeline (TransBioLine) Project, aims to generate exploratory and confirmatory data supporting regulatory qualification and acceptance of novel safety biomarkers for five target organ systems (kidney, liver, pancreas, vascular, and central nervous system) for application in drug development.
In March 2019, Summa Equity acquired Olink Proteomics, a Swedish life science company that has developed a unique technology for human biomarker discovery, targeting the global biopharma and academic research and discovery markets.
In December 2018, Olink Proteomics launched Olink® ONCOLOGY III, a new oncology-focused biomarker panel that complements and expands on Olink’s growing portfolio of thoroughly validated assays, extending the power of the Olink platform for discovery-scale applications to 1164 different human protein biomarkers.

View full report: https://www.datamintelligence.com/research-report/biomarkers-market

Enquiry before buying: https://www.datamintelligence.com/enquiry/biomarkers-market

About Us

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Breakfast Cereals Market, Size, Share, Outlook and Growth Opportunities 2019-2026

5:50 pm 27 July 2020

Market Overview

The global breakfast cereals market is expected to grow at a CAGR of 5% during the forecast period (2019-2026)
The fast-paced lifestyles across the globe has been forcing traditional breakfast foods such as porridges, buns and breads to get replaced by convenient products. The on-the-go Breakfast cereals evolved as healthy alternative owing to its nutritional benefits and convenience. Breakfast cereals are conventional food categories processed from grains such as Wheat, Oats, Rice, and Corn. Breakfast cereals are high in fiber and nutrients, and contain very low cholesterol. These food products are available as hot cereals and ready to eat cereals.

Download free sample: https://www.datamintelligence.com/download-sample/breakfast-cereals-market

Market Dynamics

The global breakfast cereals market growth is majorly driven by the need for nutritious food as breakfast to help fuel the physical and mental health. Rising risk of diseases such as Diabetes, Obesity, and cardiac issues owing to sedentary lifestyles is motivating people towards consumption of low-calorie food, thereby boosting the demand for breakfast cereals. A porridge made of whole grains contain zero cholesterol, thus making it ideal food for heart health. Furthermore, the growing cereal production across the world is also supporting the growth of breakfast cereals market. According to OECD-FAO Agricultural Outlook 2018-2027, the global cereal production is likely to grow by 13% between 2018 and 2027. The consumption of cereals is projected to witness 14% growth over the same period to reach 2.9 billion tons in 2027 and this growth is attributable to human food uses. The development of organic cereals is estimated to provide new growth avenues to the breakfast cereals market over the forecast period. Organic cereals are holding the health-savvy population who would otherwise shift towards alternatives owing to GMO issues of cereals.
The adverse health effects of cereals on human health if consumed heavily is hindering the growth of Breakfast Cereals Market. Over consumption of cereals increase the risk of Arthritis. Furthermore, added sugar content of these products is limiting the growth of the market. The manufacturers of breakfast cereals add artificial sweeteners to enhance the consumer sensory experience. However, over intake of sugar may result in type-2 Diabetes and heart disease.

Market Segment Analysis

By product type, the Breakfast Cereals Market is segmented into bars, flakes, fillows, granola and others. Among all, flakes is the largest segment with wide consumer base and a significant market share. Most of the renowned companies including Kellogg’s, Nestle, and General Mills are promoting flakes processed from Corn and Wheat as one of their key breakfast cereal products owing to the demand for this products. Moreover, companies are focusing towards flavored cereal products with high sugar content to gain significant traction among kids. Apple, cranberries, strawberries, and coconut are the major flavors available in the global market. The potential of these flavors to balance the inherent taste of cereal bases is enhancing the consumer spectrum for flavored breakfast cereals among adult population.

Geographical Share

North America is dominating the global Breakfast Cereals Market in 2018 and estimated to hold a share of XX% in 2018 owing to the large consumer base for these products. Need for ready to eat food coupled with modernization made North America along with several European nations as the early adopter of breakfast cereals. However, Asia Pacific region evolved as the fastest growing market for breakfast cereals owing to the rising disposable income, growing retail market and convenience stores in the region. Many startup companies have recently entered into the market with innovative product formulations and are boosting sales significantly. For instance, Bangalore based Kottaram Agro Foods Pvt Ltd that makes breakfast cereals under the brand Soulfull received an investment of $5.37 million in March 2018. The sales of the company is likely to grow by 5X times by the end of 2019.

Competitive Analysis

The Breakfast Cereals Market is highly competitive with new players entering the market. Some of the major players include The Kellogg Company, General Mills, Inc., Nestlé S.A., PepsiCo, Inc., and Clif Bar & Company. The key players are adopting various key strategies such as product launches, collaborations, mergers & acquisitions which are contributing to the growth of the Breakfast Cereals Market globally. For instance,
The Kellogg Company is eyeing to buy a stake in Indian based Haldiram's to boost its snack business in the country. The alliance will also provide an opportunity to diversify its portfolio of breakfast cereals in Western India.
In June 2016, The Kellogg Company acquired Pure Organic, U.S. based manufacturer of organic breakfast bars. This acquisition marked the boom of organic cereals in the breakfast cereals market.
quisition marked the boom of organic cereals in the breakfast cereals market.

View full report: https://www.datamintelligence.com/research-report/breakfast-cereals-market

Enquiry before buying: https://www.datamintelligence.com/enquiry/breakfast-cereals-market

About Us

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Automotive Electric Motors for EV Market, Size, Share, Outlook and Growth Opportunities 2019-2026

5:49 pm 27 July 2020

Market Overview

Global Automotive Electric Motors for EV Market is expected to grow at a CAGR of 22.5 % during the forecast period (2019-2026). Due to the rising demand for Electric Vehicles all around the world will drive the future growth of the global automotive electric motor for the EV market.
An electric motor is an electrical machine that converts electrical energy into mechanical energy. Most electric motors operate through the interaction between the motor's magnetic field and electric current in a wire winding to generate force in the form of rotation of a shaft. Electric motors can be powered by direct current (DC) sources, such as from batteries, motor vehicles or rectifiers, or by alternating current (AC) sources, such as a power grid, inverters or electrical generators. The motors are finding their application in the automotive sector to due to the Electric Vehicle rise, and they require motors for driving using battery.
The report covers all the major trends and drivers playing a key role in the growth of the Automotive Electric Motors for EV market.

Download free sample: https://www.datamintelligence.com/download-sample/automotive-electric-motors-for-ev-market

Market Dynamics

The global Automotive Electric Motors for EV is primarily driven by rise in demand for vehicles running on alternative fuels such as EVs coupled with introduction of regulation pertaining to reducing carbon footprint and global warning will fuel growth in the global automotive electric motor for EV market during the forecast period.
According to International Energy Agency (IEA), in 2017, more than one Billion EVs were sold globally, with countries like Norway, China, and the US dominating the global EVs market in terms of market share.
With the stringent government rules and regulations with respect to vehicular emission will also boost the market for the Electric Vehicle market all around the world, which will further increase the market for the electric motors for the production of Electric Vehicles.
For Instance, Norway has become the world’s EV capital, thanks to generous purchase subsidies and other incentives. EVs are exempt from acquisition tax and from the country’s 25 percent value-added tax. They also enjoy privileged status on the roads, with exemptions from tolls, free ferry rides and, in some cities, free parking. Last year, pure electric cars accounted for over 20% of new registrations.
However, the shortage of EV charging stations has been hindering the adoption of these vehicles, which in turn, is expected to restrict the usage of electric motors for electric vehicles.

Market Segmentation

By Vehicle type, the global Automotive Electric Motors for EV market is segmented into Pure Electric Vehicles (PEV), Hybrid Electric Vehicles (HEV), Plug-In Hybrid Electric Vehicles (PHEV). In 2018, Plug-In Hybrid Electric Vehicles (PHEV) dominated the global Automotive Electric Motors for EV market and is expected to retain its dominance in the forecasted period, mainly due to major competitors in the market are launching PHEV with the environmental safety factors as well as features like external power source can be used for charging the cars’ battery. Unlike HEVs and PHEVs, BEVs does not have petrol engine, fuel tank or exhaust pipe and are fully electric vehicles with batteries which can be charged via charging stations and power outlet.
For instance, in February 2019, Audi has announced that they will release a whole new range of PHEVs based on existing cars at the upcoming Geneva Motor Show. The launch will be limited to Audi A8, A7 Sportback, A6 and Q5 models only. All of which will get two variant options, with variations to the performance and the equipment. Driving range from Audi’s 14.1 KwH battery rated to 385 Volts is expected to be 40 kms according to the more stringent WLTP cycle.
By Motor, the global Automotive Electric Motors for EV market is segmented into AC Motor and DC Motor. DC Motor has the dominant position in the Automotive Electric Motors for EV market due to following advantages higher speed ranges, noiseless operation, faster dynamic response, better speed versus torque characteristics and others. However, AC motor market will be rising with double digit growth rate due the reason that AC electric car motors generate favorable torque, thus helping the transmission to last longer and have low cost than DC motor with permanent magnet.

Geographical Analysis

By geography, the global Automotive Electric Motors for EV market is segmented into North America, Asia-Pacific (APAC), Europe, South America, and Middle East and Africa (MEA).
Europe holds the largest market share for Automotive Electric Motors for EV due to Several laws and regulations have been enacted by countries to monitor vehicular emission. Many countries have adopted previous versions of European or United Nations Economic Commission for Europe (“UN-ECE”) mobile source emission regulations. Some countries have adopted more advanced regulations based on the most recent version of the European regulations. BEVs and PHEVs are primarily powered by batteries. Various countries are taking initiatives in direction of lowering global warming. And with continuous rise in infrastructure for charging stations for EV in Europe will also boost the market for the forecast period.
Europe is ahead of its stated policy goal of one charging station per 10 electric vehicles, but the number of charging points will have to rise quickly to keep up with an EV fleet that BloombergNEF projects to reach more than 30 million by 2030. The continent will add its 200,000th point this year, and the number of EVs is expected to reach 2 million next year. Germany, the Netherlands, France and the U.K. lead in EV infrastructure, accounting for 66 percent of charging points and 60 percent of the increase in stations since 2014.
North America is after Europe in terms of market share of Automotive Electric Motors for EV due to the rise in awareness among the people in the region for the environmental safety and also the stringent regulation by the government will grow market for EVs, hence boosting the market for the Electric motors for EV.

Competitive Analysis

Key players are adopting strategies such as investing in R&D, new product launches, expansion in distribution channels to stand out as strong competitors in the market. Global Automotive Electric Motors for EV is a competitive market with the presence of various global and regional players in the market.
The major players Denso, Mitsubishi Electric, Emerson Electric Company, Baldor Electric Company, and Hitachi Automotive Systems. Other key players in the market include Siemens Ag, Yasakawa Electric, Robert Bosch Gmbh, Toshiba Corporation, and Magna International.

View full report: https://www.datamintelligence.com/research-report/automotive-electric-motors-for-ev-market

Enquiry before buying: https://www.datamintelligence.com/enquiry/automotive-electric-motors-for-ev-market

About Us

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Apiculture Market, Size, Share, Outlook and Growth Opportunities 2019-2026

5:48 pm 27 July 2020

Market Overview

The Global Apiculture Market is expected to grow at a CAGR of 2.6 % during the forecasting period (2019-2026).
Apiculture is a process of maintaining bee colonies to obtain honey and honey-based ends products such as beeswax, propolis, royal jelly, and honeydew. Beekeeper aligns bees in an order through hives to collect honey and other by-products. Beekeeping was initially started in North Africa and expanded to Europe through Egypt in the mid-18th Century. An increase in demand for honey and insufficient availability of natural honey led to increasing in establishments of commercial farms for beekeeping across the globe. Key benefits associated with apiculture in commercial farms include low maintenance and enhanced pollination activities across the farms.

Download free sample: https://www.datamintelligence.com/download-sample/apiculture-market

Market Dynamics:

Growing demand for honey from various industries is the major factor driving the global apiculture market. The consumption of honey is rapidly surging in food and beverages industry as flavoring and sweetening agent owing to the adverse health effects of sugar-based sweeteners, thus providing equal market growth for global apiculture market. According to FAO, the annual production of honey in turkey increased from 106,000 tons in 2016 to 114 thousand tons in 2017 providing equal market growth for global apiculture market. The market has seen growing establishments of new colonies and beekeeping enterprises for honey production to cater the growing demand. For instance, the number of beekeeping enterprises increased from 7814 units in 2017 to 8552 units in 2018, stated the Ministry for Primary Industries New Zealand. According to National Agricultural Statistics Service, total number of colonies in the U.S increase from 2.683 million colonies in 2017 to 2.803 honey bee colonies in 2018 witnessing a growth in annual honey production from bee colonies from 74,500 thousand tons in 2017 to 76,150 thousand tons in 2018. Growing interest by entrepreneurs in bee farming and increase in support for beekeeping enterprises is expected to boost the global apiculture market during the forecast period.
Impact of environmental factors such as high temperature, the effect of pests and lack of awareness among beekeepers are the factors hindering the growth of the global Apiculture market.

Market Segment Analysis

Global apiculture market is segmented on the basis of hive type into traditional hives, Kenyan top bar hives, and Langstroth hives. Langstroth dominate the global apiculture market owing to its extensive usage by the beekeepers in the developed countries owing to its advantages over the traditional hives. Compact honey production, easy harvesting technology and quick extracting process are the key advantages attained by bee keepers through adoption of Langstroth apiculture hives.
By Application, global apiculture market is segmented into Medical, Food & Beverages, Cosmetics and other applications. Food & Beverages segment dominate the global apiculture market owing to extensive usage of honey as source of sweetening and flavoring agent. Growing consumer preference towards low-calorie, natural and healthy sweeteners led to increase in adoption of honey as sweetening agent by major beverages producers across the globe. According to U.S department of Agriculture in 2015, more than 51% of honey in the United States is used by the food processers in prepared & packaged food, chefs and food service operators. While, rest 49% of honey is used as non-food applications as personal & beauty products and retail sales.

Market Geographical Presentation

By region, the global apiculture market is segmented into North America, South America, Europe, Asia-Pacific, Middle-east and America.
Asia-Pacific is expected to dominate the global apiculture market owing to high presence of honey producing capabilities and growing establishments of commercial honey producers across the region. Lack of honey production resources in developing nations led to increased dependency on Asian countries for honey imports. According to FAO, China dominated the global production of honey with a share of 29% followed by the European Union with 12%. Growing government initiatives programs for installation of commercial honey farms is expected to boost the Asia-Pacific apiculture market. During the period 2015-16 Khadi and Village Industries Commission initiated program for training 2 Lakh people in beekeeping technologies and supporting new bee keepers under Entrepreneurship Development program under PMEGP. Indian Ministry of Agriculture & Farmers Welfare had commissioned 3 integrated beekeeping development centers in 2015-16 for the promotion of beekeeping technology across the country.
According to European Commission Agricultural and Rural Development in 2019, the number of hives in the European Union increased from 16,633 units in 2017 to 17,577 units in 2018. The beekeepers in the European Union is expected to increase from 606,082 in 2017-19 to 652,305 units in 2020-22. Number of beekeepers in the European Union is expected to increase during the forecast period to meet the consumer demand for honey and honey-based end products. According to Eurostat Comext, the annual imports of honey in European Union increased from 194,466 tons in 2016 to 207,412 tons in 2018. High imports tariffs imposed by the exporting nations in honey is expected to boost the establishments of commercial honey farms across the European Union.

Market Competitive Analysis

The global apiculture market is highly fragmented with large number of beekeeping farms across the globe. The market is equipped by the foothold of several private and family-owned businesses. These companies are focusing on their business development through increased bee colonies.
Apart from increasing bee colonies, acquisition is also considered as business growth strategy to help improve their geographical presence and market share. For instance,
In November 2018, Mann Lake acquired Kelley beekeeping in support with Grey Mountain Partners to improve its presence/foothold in the United States beekeeping industry.
Some of the key players in the global Apiculture market include Betterbee, Gloden bees Ltd, Mann Lake Ltd., and Tiwana Bee farm.

View full report: https://www.datamintelligence.com/research-report/apiculture-market

Enquiry before buying: https://www.datamintelligence.com/enquiry/apiculture-market

About Us

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Antidepressant Drugs Market, Size, Share, Outlook and Growth Opportunities 2019-2026

5:47 pm 27 July 2020

Market Overview

Global Antidepressant Drugs Market Expected to reach a high CAGR of 5.4% By 2026: DataM Intelligence
Antidepressants are medications that can help relieve depression symptoms. The objective is to correct the chemical imbalances of neurotransmitters in the brain that are believed to be responsible for changes in behavior and mood. They can also be used to treat several other conditions, including generalized anxiety disorder, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), and are sometimes used when treating people with chronic pains. Although antidepressants can treat the symptoms of depression, they don't address the causes, hence are typically used in combination with other therapies.

Download free sample: https://www.datamintelligence.com/download-sample/antidepressant-drugs-market

Market Dynamics

The global market for the Antidepressant Drugs The market is primarily driven by the increase in the prevalence of depression, raising awareness regarding depression, and required clinical needs. According to WHO, depression affects 300 million people worldwide and is a common illness. Depression can become a severe health condition when long-lasting with moderate or severe intensity and can even lead to suicide. According to the WHO, there were an estimated 793,000 suicide deaths worldwide in 2016, and approximately 800,000 people die due to suicide every year. Moreover, the rising number of people suffering from stress, the emergence of novel drugs with lesser side-effects and growing elderly population, who are prone to suffer from subsyndromal depression, are expected to drive the market further. An estimated 70.9 million prescriptions for antidepressants were given in England in 2018, which has almost doubled in the past decade when compared with 36 million given out in 2008.
However, the preference of non-pharmacological therapies over pharmacological therapies, its reduced efficacy and patent expiry of antidepressants leading to a weak pipeline may hinder market progress.

Market Segment Analysis

By Drug Class, the global Antidepressant Drugs market is segmented into Monoamine oxidase inhibitors, Norepinephrine-Dopamine Reuptake Inhibitor, Serotonin-norepinephrine reuptake inhibitors, Selective serotonin reuptake inhibitors, Tricyclic antidepressants, and others. Selective serotonin reuptake inhibitors (SSRIs) hold the most substantial market share and are the most commonly prescribed antidepressants owing to efficacy and safety. Moreover, they have fewer side effects than other antidepressants.
By depression disorder, the global antidepressant drugs market is segmented into major depressive disorder, obsessive-compulsive disorder, generalized anxiety disorder, panic disorder, and others. The major depressive disorder is the most prevalent as it can be caused by a combination of distress from psychological, biological, and social sources. Some significant risk factors include chronic health problems, substance abuse, family history, and drastic life changes. According to the CDC, an estimated 17.3 million adults in the US had at least one major depressive episode, which represented 7.1% of all US adults. A CDC study shows that postpartum depression estimates can be as high as 1 in 5 women in the US.

Market Geographical Analysis

North America accounts for the largest share in the global antidepressant drugs market. This can be mainly attributed to factors the increasing prevalence of depression and government incentives to promote awareness regarding depression. According to the CDC, more than 8% of adults older than 20 reported having depression during a given two-week period in the US. According to the Anxiety Disorders Association of America, in the US, anxiety disorders are the most common mental illness affecting 40 million adults (18.1%) age 18 and older annually. Generalized anxiety disorder affects 6.8 million (3.1%) adults, panic disorder affects 6 million (2.7%) adults, and post-traumatic stress disorder affects 7.7 million (3.5%) adults, major depressive disorder affects more than 16.1 million (6.7%) the US adults, and persistent depressive disorder, also known as dysthymia, affects approximately 1.5% of the US population. Moreover, the advanced regional healthcare infrastructure, easy availability of medication, the presence of established market players, and high investment in R&D activities by them are likely to boost the North America antidepressant drugs market growth.

Market Competitive Analysis

Companies are increasing their user base and improving their antidepressant drugs market presence by FDA approvals and investing in R&D. Moreover, several key companies have adopted merger and acquisitions policies, geographic expansion, and collaborations to gain competitors edge in the market and also to expand its sales in the global antidepressant drugs market.
Major Players in the global anti-depressant drugs market include Allergan plc, Pfizer Inc., Novartis AG, AstraZeneca PLC, and Johnson & Johnson.
In May 2019, Allergan plc and Gedeon Richter Plc. announced FDA approval of supplemental New Drug Application (sNDA) for VRAYLAR (cariprazine) for expanded use to treat depressive episodes associated with bipolar depression in adults. VRAYLAR is also approved in the U.S. to treat manic or mixed episodes associated with bipolar I disorder in adults.
In March 2019, the FDA approved a Johnson & Johnson nasal spray antidepressant for people resistant to other treatments. The drug, a nasal spray called Spravato (esketamine) acts within hours, rather than weeks or months as is typical for current antidepressants.
In March 2019, Sage Therapeutics received FDA approval for ZULRESSO (brexanolone) injection for the treatment of postpartum depression (PPD). ZULRESSO is the only specifically approved drug for the treatment of PPD, the most common medical complication of childbirth.
In July 2018, FDA granted fast track designationfor Allergan’s investigational new treatment for the major depressive disorder - AGN-241751. AGN-241751 is a novel, oral, rapid-acting anti-depressant that recently entered Phase 2 development.
In July 2015, FDA approved Otsuka’s Rexulti (brexpiprazole) for the treatment of depression and schizophrenia.

Key Takeaways:

The global market for the Antidepressant Drugs Market is primarily driven by the increase in the prevalence of depression, raising awareness regarding depression, and required clinical needs.
Selective serotonin reuptake inhibitors (SSRIs) hold the most substantial market share and are the most commonly prescribed antidepressants owing to efficacy and safety.
North America accounts for the dominant share in the global antidepressant drugs market. This can be mainly attributed to factors the increasing prevalence of depression and government incentives to promote awareness regarding depression.
Companies are increasing their user base and improving their Antidepressant Drugs market presence by FDA approvals and investing in R&D. For instance, in July 2015, FDA Approved Rexulti (brexpiprazole) from Otsuka for the treatment of depression and schizophrenia.

View full report: https://www.datamintelligence.com/research-report/antidepressant-drugs-market

Enquiry before buying: https://www.datamintelligence.com/enquiry/antidepressant-drugs-market

About Us

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Anti-viral Therapeutics Market, Size, Share, Outlook and Growth Opportunities 2019-2026

5:47 pm 27 July 2020

Market Overview

The Global Anti-viral Therapeutics Market is expected to grow at a CAGR of 3.8% during the forecasting period (2019-2026).
Antiviral drugs are a class of medication, which are used in treating viral infections, and most antivirals are used for specific viral infections. Antiviral drugs are sold prescription-based only and are different from antibiotics, which fight against bacterial infections. Unlike most antibiotics, antiviral medication does not destroy the target pathogen, but instead, they obstruct the development. Most antiviral drugs currently available are to help deal with herpes viruses, HIV, influenza A, and B viruses, and hepatitis B, and C viruses. Moreover, researchers are working on expanding the range of antivirals to other families of pathogens.

Download free sample: https://www.datamintelligence.com/download-sample/anti-viral-therapeutics-market

Market Dynamics

The global market for the Antiviral Therapeutics The market is primarily driven by the growing incidents of viral infections among populations. According to UNAIDS, in 2017, there were an estimated 36.9 million people [31.1 million–43.9 million] worldwide living with HIV/AIDS, of which 1.8 million were children (15 years old and below), and an estimated 1.8 million individuals became newly infected with HIV. According to the World Health Organization (WHO), an estimated 257 million people are living with hepatitis B virus infection, and in 2015, hepatitis B resulted in 887 000 deaths. WHO estimated that 71 million people are infected with hepatitis C worldwide. Moreover, strong R&D, increasing product launches, a strong pipeline for antiviral drugs coupled with the increasing awareness on viral infections and their treatments are of the key drivers in the antiviral therapeutics market growth. For instance, in May 2019, Atriva Therapeutics GmbH announced the first dose up of its lead drug candidate ATR-002 in a Phase I clinical trial, marks the start of the clinical development of a novel host-targeted approach to treating influenza virus infections. However, the patent expiration of blockbuster drugs and the high cost of Antiviral therapeutics may hinder market progress.

Market Segmentation

By Application, the Global Antiviral Therapeutics Market is segmented into HIV, Hepatitis, Herpes Simplex Virus, Influenza, and others. The HIV application holds the largest market share owing to its growing prevalence worldwide and an increasing number of drug launches coupled with several drugs currently in the pipeline. According to UNAIDS, in 2017, there were approximately 1.8 million people [1.4 million–2.4 million] who became newly infected with HIV worldwide and nearly 21.7 million people of the total 36.9 million people living with HIV/AIDS were receiving antiretroviral therapy. For instance, in 2018 alone, there were four drugs (Trogarzo, Biktarvy, Delstrigo, and Symtuza) approved by the FDA for the treatment of HIV. However, Hepatitis application is anticipated to show significant market growth, increasing R&D expenditure by key players, and approval of combination antiviral therapies. For instance, in May 2019, Cocrystal Pharma Inc., a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, begun patient enrolment in its Phase 2a open-label study. The study will evaluate the safety, tolerability, and preliminary efficacy of Cocrystal’s CC-31244 in combination with Daclatasvir and Sofosbuvir with and without protease inhibitors, for the treatment of hepatitis C.
By Mechanism of Action, the Global Antiviral Therapeutics Market is segmented into Nucleotide Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, and others. The Reverse Transcriptase Inhibitor segment held the most significant market share owing to its high demand and broad product range for the treatment of HIV.

Geographical Analysis

North America accounts for the largest share in the global Antiviral Therapeutics market and is mainly attributed to the growing prevalence of HIV, Hepatitis infections, and Influenza in the region. According to the CDC in 2016, an estimated 38,700 people became newly infected with HIV in the US, and approximately 1.1 million people in the US are living with HIV. CDC reported a total of 3,218 cases of acute hepatitis B, with an overall incidence rate of 1.0 cases per 100,000 population in 2016 and CDC estimates that 800,000 to 2.2 million people in the United States have chronic hepatitis B. Moreover, the advanced regional healthcare infrastructure, high level of drug development, presence of established market players, rise in healthcare expenditure, and high investment in R&D activities by them are likely to boost the North America Antiviral Therapeutics market growth.

Competitive Analysis

Several key companies have adopted merger and acquisitions policies, geographic expansion, and collaborations to help them to stand out as strong competitors in the market and also expand its sales in the global Anti-viral Therapeutics market. Moreover, the increasing FDA approvals, product launches, and robust pipeline are improving key players’ market presence.
Major Players in the global Anti-viral Therapeutics market include Roche, Gilead Sciences, GlaxoSmithKline, Bristol-Myers Squibb, Johnson & Johnson and Merck.
In June 2019, Cidara Therapeutics Inc., a biotechnology company developing novel anti-infectives including immunotherapies, announced that new data from studies of CB-012, its Cloudbreak antiviral Fc-conjugate (AVC) candidate for influenza. CB-012 is the first AVC candidate generated by Cidara’s Cloudbreak anti-infective immunotherapy platform.
In April 2019, the US FDA approved Dovato (dolutegravir and lamivudine), as a complete regimen for the treatment of HIV-1 infection in adults with no antiretroviral treatment history and with no known or suspected substitutions associated with resistance to the individual components of Dovato. This is the first FDA-approved two-drug, FDC regimen for HIV-infected adults who have never received treatment for HIV.

View full report: https://www.datamintelligence.com/research-report/anti-viral-therapeutics-market

Enquiry before buying: https://www.datamintelligence.com/enquiry/anti-viral-therapeutics-market

About Us

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Antacids Market, Size, Share, Outlook and Growth Opportunities 2019-2026

5:46 pm 27 July 2020

Market Overview

The Global Antacids Market is expected to grow at a CAGR of 3.1% during the forecasting period (2019-2026). Antacids are the over the counter medications used in neutralizing the stomach acid. They mainly work by reducing or preventing the secretion of stomach acids. They are mostly used in treating acid reflux, heartburn, indigestion. Growing prevalence of gastroesophageal reflux diseases and peptic ulcers is one of the primary drivers of the market, creating lucrative opportunities' for the pharmaceutical companies to manufacture different drugs to meet the demand.

Download free sample: https://www.datamintelligence.com/download-sample/antacids-market

Market Dynamics

Global Antacids market growth is driven by increasing prevalence of gastroesophageal reflux diseases, rising prevalence of heartburn, and increasing awareness about GERD and increasing side-effects related to non-steroidal anti-inflammatory drugs.
Increasing prevalence of GERD is one of the dominating factor propelling the global antacids market. For instance, according to a review article published in the International Foundation for Gastrointestinal Disorders in 2014, the prevalence estimates of GERD since 1995, in North America were around 18% to 28%, Europe had 9% to 26%, East Asia had 3% to 8%, Australia had about 12% and 9% to 33% in the Middle East, and 23% in South America. It is also suggested that there was an increase in GERD prevalence since 1995, mainly in North America and East Asia.
Rising prevalence of heartburn is expected to boost the market over the period of forecast. According to the American college of gastroenterology, more than 60 million Americans will experience heartburn at least once a month and more than 15 million Americans experience heartburn symptoms every day.
Increasing awareness about GERD is expected to boost the market. For instance, the International Foundation for Gastrointestinal Disorders has provided the information and support regarding GERDin the 19th Annual GERD Awareness Week, which was in November 2018. Also, it helps in educating individuals related to GERD and supports research regarding treatments and cures for GI disorders.
However, alternative treatment for antacids and increased side-effects related to antacids are hampering the market. For instance, alternative treatments which are likely to restrict the market for antacids include acupuncture, melatonin, hypnotherapy, herbal remedies, baking soda and lifestyle changes. Also, side effects related to antacids include dose-dependent rebound hyperacidity, milk-alkali syndrome, aluminium intoxication, osteomalacia, and hypophosphatemia are restraining the market growth.

Market Segmentation Analysis

Based on drug class, the global antibacterial drugs market is segmented into proton pump inhibitors, H2 antagonists, and Acid neutralizers.
Proton pump inhibitors segment is expected to grow at a significant rate over the period of forecast. This is owing to Prescription PPI’s, easy availability of OTC PPI’s. Due to the acid-suppressing effects, they are approved for several short term indications like GERD, erosive esophagitis and duodenal and gastric ulcers. Long term indications include NSAID’s associated gastric ulcers, hypersecretory conditions, and maintenance of healing erosive esophagitis. For instance, the currently available PPI’s include omeprazole (Prilosec), lansoprazole (Prevacid), pantoprazole (Protonix), rabeprazole (Aciphex), esomeprazole (Nexium), dexlansoprazole (Dexilant) and Omeprazole with sodium bicarbonate (Zegerid, Zegerid OTC). A clinical trial related to PPI’s is expected to drive the market. For instance, according to Pulmonary Fibrosis News on January 25, 2019, a large, multi-centre clinical trial testing the proton pump inhibitor omeprazole was done as a therapy for cough in idiopathic pulmonary fibrosis (IPF) patients. It seems to be achievable and justified, according to the results of a single-centre pilot trial.
Based on formulation type, the global antacids drugs market is segmented into tablet, liquid and powder.Tablet segment is expected to grow at a significant rate over the period of forecast. This is owing to the accurate dosage and secure storage of tablets when compared to other conventional formulations. Also, the presence of chewable tablets in the market with various flavours leading to improved patient adherence is expected to drive the market. For instance, Merck’s Pepcid Complete for heartburn associated with acid indigestion and sour stomach, Aciphex (rabeprazole sodium) of Elan Pharmaceuticals for treating symptomatic GERD and Protonix (pantoprazole sodium) Delayed-Release Tablets of Wyeth for treating Short-term treatment of erosive esophagitis associated GERD are some of the antacid tablets prevailing in the market.
Liquids segment is expected to grow at a high rate over the period of forecast. This is owing to the added advantages like a faster release, palatable taste. This is giving lucrative opportunities’ for the key players to manufacture liquid antacids. For instance, Pfizer’s Gelusil plus and Pepticaine, Gaviscon liquid OTC of GlaxoSmithKline, Maalox of Sanofi, Mylanta OTC of McNeil Consumer Healthcare are some of the popular liquid antacids in the market.
Based on end-users, the global antibacterial drugs market is segmented into hospital pharmacies, retail pharmacies and others. Retail pharmacies segment is expected to hold a significant market share over the period of forecast. This is owing to the easy availability and accessibility of a large number of OTC drugs present in the retail pharmacies.

Geographical Share

North America is dominating the global Antacids market in 2018 and estimated to hold the largest market size over the forecast period (2019-2026). This is owing to the rising prevalence of GERD, increasing the incidence of heartburn, increased awareness of GERD among the consumers.
Rising incidence of GERD is the dominating factor propelling the global antacids market. For instance, in 2017, CDC has reported that the number of visits in emergency departments with digestive system disorders was around 32.3 million. According to the National Institute of Diabetes and Digestive and Kidney Diseases, in 2010, 4.7 million hospitalizations and 1,653 deaths occurred due to GERD. Based on the Healthcare Cost and Utilization Project (HCUP), in 2005, there were around 3.14 million cases of GERD.Based on the National Institute of health ambulatory care visits due to GERD was 8.9 million in 2009.
Rising prevalence of heartburn is expected to boost the market over the period of forecast. According to the American college of gastroenterology, more than 60 million Americans will experience heartburn at least once a month and more than 15 million Americans experience heartburn symptoms every day. According to the researchers from the University of Michigan, acid reflux and heartburn affected more than 20% of the U.S. population in 2017.
However, over the forecast period (2019-2026), the Asia-Pacific is expected to dominate the Global Antacids market. This is owing to increased use of antacids for treating GERD and increased awareness of antacids among consumers. For instance, in August 2018,the latest reading of the Index of Industrial Production (IIP) has reported that the most significant contributor to the industrial growth in India was Digestive enzymes and antacids which include PPI drugs. Also, the presence of key players like GlaxoSmithKline, Pfizer etc. is expected to accelerate the market. For instance,Pfizer's GEP (Global Established Products) division in India launched antacid Gelusil liquid in a ready-to-drink form in 2016. Abbott’s has launched Digene gel in India for relieving peptic ulcer, hyperacidity and heartburn.

Competitive Landscape

Some of the key players in the Global Antacids market are Pfizer, GlaxoSmithKline, Abbott India Private Ltd, Merck, AstraZeneca PLC, Bayer AG, Takeda pharmaceuticals, Sun pharmaceuticals, Sanofi, Dr Reddy’s Laboratories etc.
The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, which are contributing to the growth of the Antacids market globally. For instance,
In 2016, Takeda Pharmaceutical’s has launched a proton pump inhibitor, Dexilant (Dexlansoprazole), for the treatment of GERD.
On May 31, 2017, Pfizer Limited (India) had agreed with AstraZeneca, to acquire the latter’s brand Neksium in India for a value of Rs 75 crore.
On September 2018, Abbott started "NoSecondOpinion campaign” for Digene, with the aim that people should prefer doctor’s recommendation to unsolicited advice.

View full report: https://www.datamintelligence.com/research-report/antacids-market

Enquiry before buying: https://www.datamintelligence.com/enquiry/antacids-market

About Us

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Antibacterial Drugs Market, Size, Share, Outlook and Growth Opportunities 2019-2026

5:46 pm 27 July 2020

Market Overview

Antibacterial Drugs Market Expected to reach a high CAGR of 3.29% By 2026: DataM Intelligence
Antibacterial drugs are the components that originated from natural and synthetic components to treat bacterial infections. The market is accelerated by the increasing demand for new drugs and antibacterial resistance. The global antibacterial drugs market also has a significant pipeline of drugs which is one of the major drivers. Many of the novel products in the development pipeline by the pharmaceutical companies are targeting new treatment pathways, route of administration, and mechanisms of action.

Download free sample: https://www.datamintelligence.com/download-sample/antibacterial-drugs-market

Market Dynamics

Global Antibacterial drugs market growth is driven by increased demand for antibacterial drugs due to rising prevalence of bacterial infections globally, the development of novel therapies, an increase in government policies and increased funds from other public bodies.
Rising prevalence of bacterial infections is one of the dominating factors boosting the market. According to the global burden of disease study 2015, lower respiratory tract infections (LRIs) have caused 2·74 million deaths. Diarrhoea was estimated to be a leading cause of death among all ages and caused 1·31 million deaths. According to TBFACTS.org it is estimated that 1.5 million people died from the disease in 2014, including 400,000 individuals who were also HIV positive. According to WHO in 2016, lower respiratory infections caused 3.0 million deaths, diarrheal diseases caused 1.4 million deaths and tuberculosis led to 1.3 million deaths.
Government initiatives are expected to boost the market over the period of forecast. For instance, in October 2015, WHO has launched the Global Antimicrobial Surveillance System (GLASS) which works with WHO Collaborating Centers and existing antimicrobial resistance surveillance networks. TB drug resistance surveillance has been implemented in 188 countries over the past 24 years. Also, a joint initiative of WHO and Drugs for Neglected Diseases initiative (DNDi), encourages research and development through public-private partnerships for the antibiotic resistance. It is estimated that by 2023, the partnership aims to develop and produce up to four new treatments, through the improvement of existing antibiotics and fuelling of the entry of new antibiotic drugs.
The increased antibacterial resistance is leading to the development of newer antimicrobials with new modes of action which can act against the multi-drug resistant strains. According to WHO, in the US, 23,000 people die as a result of antibacterial resistance every year. To tackle this, On June 26, 2018, Achaogen’s ZEMDRI™ (plazomicin) was approved by FDA for the treatment of adults with complicated urinary tract infections (cUTI) including pyelonephritis, caused by Enterobacteriaceae in patients who have limited treatment options.
Robust pipeline is expected to boost the global antibacterial drugs market over the period of forecast. In June 2018, around 42 new antibiotics are with the potential to treat bacterial infections and are in clinical development. For instance, drugs in phase 1 include TP-271 and TP-6076 of Tetraphase Pharmaceuticals Inc which belong to tetracycline drug class. Drugs in phase 2 include Otsuka Pharmaceutical Co. Ltd’s OPS-2071 of the quinolone class.
However, genetic mutations, the toxicity of antibacterial drugs are expected to hamper the market. For instance, spontaneous mutations acquired from other bacteria through horizontal gene transfer make the bacteria resistant to the antibiotic. Also, toxicities related to antibacterial drugs like photosensitivity caused by fluoroquinolones are restraining the market.

Market Segment Analysis

On the basis of drug type, the global antibacterial drugs market is segmented into beta-lactams, aminoglycosides, tetracyclines, macrolides, sulfonamide, quinolones, and others.
Beta lactum antibiotics segment is expected to dominate the market over the period of forecast. This is owing to the recent FDA approvals, promising pipeline of the pharmaceutical companies. For instance, vabomere of Melinta Therapeutics Inc was approved on August 30, 2017, for complicated urinary tract infection. Cefepime +AAI1019 of Allecra, Cefiderocol (S-649266) of Shionogi & Co. Ltd. and Sulopenem of Iterum Therapeutics are in phase 3 for the treatment of complicated urinary tract infections.
The tetracycline antibiotics segment is expected to grow at a high rate over the period of forecast. This is owing to the increased number of FDA approvals and the promising pipeline of key players. For instance, omadacycline of Paratek Pharmaceuticals Inc. was approved in October 2018 for the treatment of community-acquired bacterial pneumonia and acute skin and skin structure infections. Xerava (eravacycline) of Tetraphase Pharmaceuticals was approved in August 2018 for treating complicated intra-abdominal infections. On March 15, 2018, Australian company Mayne Pharma has announced a launch of a generic version of doxycycline monohydrate immediate release capsules in the US. Several drugs in phase 1 are anticipated to be approved in the forecast period. For instance, KBP-7072 of KBP BioSciences Pharmaceutical Technical Co. Ltd and TP-271 of Tetra phase Pharmaceuticals Inc. are used for treating Community-acquired bacterial pneumonia.
On the basis of end-users, the global antibacterial drugs market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The retail stores and drug stores segment is expected to grow at a significant over the forecast period. This is owing to the increase in the number of retail drug stores, and the availability of antibacterial drugs in retail pharmacies and drug stores. According to the survey conducted in 2014, the majority of drug stores around 93.5% were prescribing antibiotics, especially amoxicillin and trimethoprim-sulfamethoxazole (septrin). A multi-country survey conducted by the WHO showed that around 93% of people obtained their antibiotics from a pharmacy or medical store.

Market Geographical Analysis

North America is dominating the global Antibacterial Drugs market in 2018 and estimated to hold the largest market size over the forecast period (2019-2026) owing to the rising prevalence of infectious diseases, increased antibiotic resistance, government initiatives and increased FDA approvals in the region, high treatment rate and improved diagnosis.
Rising prevalence is one of the dominating factors propelling the market. FDA approved drugs in the region, high treatment rate and improved diagnosis. For instance, According to CDC in 2016, in the US, there were around 9272 cases of tuberculosis, and 53,850 cases of salmonella.
Increased antibiotic resistance is expected to boost the market over the period of forecast. For instance, in 2013, CDC has reported that such infections will kill at least 23,000 people each year in the US alone. According to the National Institute of Health, around 20,000 people in the US are infected with vancomycin-resistant enterococci every year, and less than 10% of those infections are fatal. According to WHO, in US, at least 2 million people have a treatment-resistant bacterial infection, and more than 23,000 people die as a result of this.
Government initiatives, like Generating Antibiotics Incentives Now (GAIN) Act in U.S., are expected to boost the market over the forecast period. In September 2014, US National Strategy for Combating Antibiotic-Resistant Bacteria was developed.
Increased number of FDA approvals in the region is expected to boost the market. For instance, Ceftazidime/avibactam (Avycaz) of Sanofi in February 1, 2018, Ceftolozane/tazobactam (Zerbaxa) of Astellas in June 3, 2018, Dalbavancin (Xydalba) of Lepetit Research Center/Vicuron and Oritavancin (Orbactiv) of Eli Lilly in 2014 are some of the drugs approved in US.

Market Competitive Landscape

Some of the major players in the Antibacterial drugs market are Pfizer, GlaxoSmithKline (GSK) and Merck & Co., Novartis AG, Sanofi, AstraZeneca, Bristol-Myers Squibb Company, Eli Lilly, Allergan, Cempra and Insmed.
The key players are adopting various key strategies such as product launches, mergers & acquisitions, partnerships, and collaborations which are contributing to the growth of the Antibacterial Drugs market globally. For instance,
On July 17, 2019, the FDA has approved Merck’s RECARBRIO™ (imipenem, cilastatin, and relebactam) for the treatment of complicated urinary tract and complicated intra-abdominal bacterial infections.
On June 3, 2019, the FDA has approved Merck’s ZERBAXA® (ceftolozane and tazobactam) for the treatment of adults with hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP).
On February 1, 2018, Allergan plc has announced that the US FDA has approved Allergan's supplemental New Drug Application (sNDA) to expand the approved use of AVYCAZ® (ceftazidime and avibactam) to include the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) caused by the susceptible Gram-negative microorganisms like Klebsiella pneumoniae, Enterobacter cloacae.
In March 2016, Obiltoxaximab of Elusys Therapeutics got FDA approval for Inhalational anthrax.

View full report: https://www.datamintelligence.com/research-report/antibacterial-drugs-market

Enquiry before buying: https://www.datamintelligence.com/enquiry/antibacterial-drugs-market

About Us

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Aloe Vera Drink Market, Size, Share, Outlook and Growth Opportunities 2019-2026

5:45 pm 27 July 2020

Market Overview

The Global Aloe Vera Drink Market is expected to grow at a CAGR of 6.9% during the forecasting period (2019-2026).
Aloe Vera is really quite an incredible plant. It is a succulent plant and part of the lily family (Liliaceae), the same family that garlic and onions belong to. Different parts of the plant are used for different effects on the body and Aloe Vera has both internal and external applications. Aloe Vera contains over 200 active components including vitamins, minerals, amino acids, enzymes, polysaccharide, and fatty acids- no wonder it’s used for such a wide range of remedies. The bulk of the Aloe Vera leaf is filled with a clear gel-like substance, which is approximately 99% water. And the freshly cut leaf is used to extract juice by crushing or grinding it.
The report covers all the major trends and drivers playing a key role in the growth of the Aloe Vera Drink market.

Download free sample: https://www.datamintelligence.com/download-sample/aloe-vera-drink-market

Market Dynamics

The global Aloe Vera Drink Market is primarily driven by health benefits that are associated with the Aloe Vera Drink and has a high demand across the globe. The Aloe Vera contains many vitamins including A, C, E, folic acid, choline, B1, B2, B3 (niacin), B6, and B12. Some of the 20 minerals found in Aloe Vera include calcium, magnesium, zinc, chromium, selenium, sodium, iron, potassium, copper, manganese. With the rich content of vitamins and minerals in Aloe Vera drink make it perfect to be consumed as a food supplement.
Increase in demand for the Aloe Vera Drinks has made the drink industry more focused on the transformation of products and to capture the market with Aloe Vera based drinks. With the rising awareness about the health benefits associated with the Aloe Vera, there has been increase in launch of flavored Aloe Vera based drinks since 2016 and it is expected to witness high demand over the forecast period.
For instance, Detoxwater, the prebiotic aloe-infused water brand, has launched an aloe supplement shot, coined Veralixir, which contains 1.7 fluid ounces of highly-concentrated aloe vera extract. Detoxwater recommends taking Veralixir once per day before or after a meal to promote digestive health, skin elasticity, nutrient absorption and immune health. The supplement contains clinically-proven ACTIValoe and is touted as being vegan, gluten-free and dairy-free.
However, due to the high cost and the adverse health effects by overconsumption of Aloe Vera drinks will be hampering the growth of Aloe Vera Drink for the forecast period.

Market Segment Analysis

By Type, the global Aloe Vera Drink Market is segmented into Flavored and Non-flavoured. Non-Flavored has the dominant position in the Aloe Vera Drink and is expected to retain its dominance in the forecasted period due to the usage as a medical drink. As with the growing digestion problem among the people because of food habits. Now the use of Aloe Vera drinks is growing due to the use as medical drinks for the remedial purpose of digestion, as Aloe is known to soothe and cleanse the digestive tract and help improve digestion. The interesting thing about taking aloe internally is that, because it is an adaptogen, it helps with either constipation or diarrhea, helping to regulate your elimination cycles in whatever way you need. It is expected that Non-flavored product will grow at a CAGR of ~YY% during the forecast period.
By distribution channel, the global Aloe Vera Drink is segmented into offline distribution channel and online distribution channel. In 2018, offline distribution accounted for more than 93% market share in the global Aloe Vera Market. However, the online channel is expected to witness double-digit growth during the forecast period.

Market Geographical Analysis

By geography, the global Aloe Vera Drink Market is segmented into North America, Asia-Pacific (APAC), Europe, South America, and the Middle East and Africa (MEA).
Asia-Pacific (APAC) holds the largest market share for Aloe Vera Drink. Due to the population growth and rising demand for drinks with high health benefits is driving the market in the region. Rising consumption from developing nations such as China and India are being the major market drivers for APAC Aloe Vera drinks market. Growing awareness among the people for the consumption of health food and drinks is the major factor for driving the market for Aloe Vera drinks. However, Europe is after APAC in terms of market share of Aloe Vera Drink, increasing demand for healthy drinks because of awareness among people for healthy food & drink and easy availability of Aloe Vera drinks in nearby hypermarket/supermarket. The Hypermarket/Supermarket culture is gaining popularity in Europe which will be driving the growth of Aloe Vera Market in the forecast period.
With investment and development in Eastern Europe are constantly growing. Poland is entering its third decade of dynamic growth with new overseas retailers and luxury brands entering the market with thirty new global brands setup operations in the country last few years. There is retail boom in Russia as 63 new complexes in 40 Russian cities have been completed. There is positive attitude in Western Europe of investment in outdated shopping centers to allow retailers to expand locally.

Market Competitive Analysis

Key players are adopting strategies such as investing in R&D, new product launches, expansion in distribution channels to stand out as strong competitors in the market. Global Aloe Vera Drink is a competitive market with the presence of various global and regional players in the market. The major players include ALO, Aloe Farms, Forever Living Products, Houssy Global, and AMB Wellness. Other key players in the market include Cady Products LLC, OKF, Lotte Chilsung Beverage Co., Ltd., AMB Wellness, and PATANJALI AYURVED LIMITED.
In April 2018, Aloe Vera drinks brand Simplee Aloe has responded to the introduction of the UK’s sugar tax by launching two new low-sugar aloe vera waters in the UK. Simplee Aloe claims the new products are the first aloe vera waters available in the country which do not use artificial ingredients, and the low-sugar drinks contain less than 2.5g of sugar per 100ml. Two variants of the drinks are available, one with aloe vera pulp and one without, as the brand seeks to appeal to a wide range of UK consumers.
In January 2018, Baidyanath Ayurved has introduced a range of four natural juices - amla, aloe vera, karela and jamun and giloy - in a bid to keep up with the increasing shift towards natural, organic and Ayurvedic products and cater to young consumers’ growing preference for fast-moving consumer goods (FMCG) that offer health benefits. These juices are both preventive and curative for health, and will be available across retail outlets.

View full report: https://www.datamintelligence.com/research-report/aloe-vera-drink-market

Enquiry before buying: https://www.datamintelligence.com/enquiry/aloe-vera-drink-market

About Us

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Agricultural Enzymes Market, Size, Share, Outlook and Growth Opportunities 2019-2026

5:44 pm 27 July 2020

Market Overview

Global Agricultural Enzymes Market is expected to grow at a CAGR of 11.1% during the forecast period (2019-2026)
Enzymes are biological products that affect plant health and have a pivotal role in overall agricultural practices. Agricultural enzymes are biological catalysts used for fastening the chemical reaction that releases nutrients in the soil to the roots in minimum time. Agricultural enzymes have the inherent property of detoxifying the soils that have processed with chemical fertilizers, herbicides, and pesticides. It also neutralizes both acid and alkaline soils and loosens heavy clay soils. In addition to crop production activities, agricultural enzymes are also used in Animal nutrition as a natural growth promoter through minimal feed consumption.

Download free sample: https://www.datamintelligence.com/download-sample/agricultural-enzymes-market

Market Dynamics

Growing demand for agricultural production owing to rising population and changing consumer dietary habits is forcing the farmers and crop growers across the globe to increase productivity. According to the statistics of the Food and Agriculture Organization (FAO), the global population is likely to reach 10 billion by 2050 and would result in a growth of over 50% in agricultural demand as compared with 2018. Enzymes are an essential tool in the armory of farmers and crop growers in meeting growing demand in a sustainable way. A recent study conducted by the Plant Scientists at Lancaster University in 2016 stated that incorporation of enzymes into farmed land boost photosynthesis in crops by 20% under some specific field conditions, which can, in turn, decrease the yield time of the output. Moreover, loss of nutrients in the soil due to erosion and extensive use of fertilizers is also motivating farmers towards supplementation of farmland with enzymes. The consumption of enzymes as soil nutrient enhancers is also witnessing a significant rise with the rising practice of organic farming by commercial farmers in developed nations through green-house farms is expected to boost the market for agricultural enzymes globally. According to a study published in the Ontario Ministry of Agriculture, Food, and Rural Affairs in 2018, the annual establishments of the greenhouse industry in Ontario and Canada increased from 36.401 million Sq.m in 2016 to 37.388 million Sq.m in 2017.
However high cost associated with the enzymes and extensive usage of conventional technologies such as fertilizers for agriculture production are hindering the growth of global agricultural enzymes market.

Market Segmentation

Global agricultural enzymes market is segmented on the basis of enzyme type into Carbohydrase, Proteases, Lipase, Phytase, and Others. Proteases evolved as the largest segment of agricultural enzymes market owing to its large-scale application in farming practices and animal nutrition. It is expected to hold its dominance over the forecast period by growing at a lucrative pace. The growth of proteases is attributable to regulatory changes and bans imposed on the use of antibiotics in animal feed. Proteases evolved as an effective alternative to antibiotics owing to its potential of improving gut and overall animal health. According to the study published in Veterinary Research in July 2018, the usage of proteases in animal feed shown similar outcomes as the usage of antibiotics.
By Application, global agricultural enzymes market is segmented into Agro-Chemicals, Animal feed Additive and others. Animal-Feed additives segment dominate the global agricultural enzymes market owing to the increase in adoption of nutritional feed additives by the commercial and local farm producers for the production of healthy cattle and poultry to meet the global demand. The usage of enzymes as a feed additive has grown at a rapid pace over the years owing to increase in adoption by the farm producers for the production of meat at a lower investment and feed consumption. Acceptance of feed enzyme technology has increased in the United States over the past twenty years. Feed enzymes have become an important tool to increase the nutritional value of feed ingredients, reduced feed consumption thereby overall reduction in feed costs, all while maintaining or improving animal growth performance.
Although the economic and social benefits of enzymes have been well established, more research and development are needed if enzymes are to reach their full potential in the industry.

Market Geographical Analysis

By region, the global agricultural enzymes market is segmented into North America, South America, Europe, Asia-Pacific, Middle-east and America.
North America is expected to dominate the global Agricultural Enzymes market owing to the high presence of organic farming and precision farming culture. Commercial farms and crop growers are investing in advanced farming technologies and use of effective materials including plant growth enzymes to meet the demand for high-quality products. Farmers are focused on producing agricultural products through sustainable practices to meet the consumer demand globally. Organic Farming focuses on optimal usage of natural resources and process for improving agricultural productivity, while minimizing negative environmental impacts such as loss of biodiversity, nutrient leakage and soil degradation through negligible usage of synthetic fertilizers. According to U.S. Department of Agriculture (USDA), number of certified organic farms in the United States increased from 8970 in 2011 to 14,000 providing significant market growth for agricultural enzymes across the region.
Asia-Pacific Agricultural Enzymes market is expected to grow at a higher pace during the forecast period owing to the high presence of poultry and cattle industry associated with the growing adoption of organic methods of farming to meet the consumer demand. According to the World of Organic Agriculture Report 2018, the total area dedicated for the organic farming activities in Asia reached over 4.9 million hectares in 2016. It has also seen that exports of organic products has also been increasing in countries like Bangladesh. India is expected to witness significant market growth during the forecast period owing to the shift in agricultural production activities from synthetic to organic methods to meet the demand for natural and organic foods from trier 1 Cities across India.

Market Competitive Analysis

The global agricultural enzymes market is consolidated with major market players such as BASF SE, Syngenta AG, Novozymes A/S, and Advanced Enzymes capturing a significant amount of market share.
Other players in the global agricultural enzymes market include American Biosystems, Agrinos AS, AB Enzymes and Creative Enzymes.
New product launches and strategic collaborations are the key strategies adopted by the prominent players in the global agricultural enzymes market to improve their geographical presence and market share. For instance,
In March 2019, Kemin Industries and China-based CRVAB Bio-Technology Ltd entered into a strategic collaboration for expansion of its production globally through technological exchange of fermentation and production capabilities with the partnering company.
In September 2018, Novozymes and DSM launched their first enzyme product, whose purpose is to improve gut functionality for broiler chickens. Moreover, this enzyme enables broilers to take up nutrients better, and poultry farmers can use less feed and move towards more sustainable production.
The market is also witnessing significant research activities and investment from major players. In August 2017, Novozymes received financing of USD 110 Billion from European Investment Bank for initiation of R&D activities in industrial enzymes and microorganisms. Key players in the market are likely to increase their R&D investments in near future to develop innovative products.
In September 2015, Bayer Biosciences and Elemental Enzymes Ag entered into collaboration in R&D activities to develop innovative products for improving crop productivity.

View full report: https://www.datamintelligence.com/research-report/agricultural-enzymes-market

Enquiry before buying: https://www.datamintelligence.com/enquiry/agricultural-enzymes-market

About Us

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence